2021 Form 10-K Financial Statement

#000121390022015818 Filed on March 29, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q2
Revenue $0.00
YoY Change
Cost Of Revenue $6.850M
YoY Change
Gross Profit -$6.850M
YoY Change
Gross Profit Margin
Selling, General & Admin $97.20K
YoY Change 9620.0%
% of Gross Profit
Research & Development $3.534M
YoY Change
% of Gross Profit
Depreciation & Amortization $365.1K
YoY Change
% of Gross Profit
Operating Expenses $1.299M
YoY Change 129758.0%
Operating Profit -$6.520M
YoY Change
Interest Expense $1.083M
YoY Change
% of Operating Profit
Other Income/Expense, Net -$380.0K
YoY Change
Pretax Income -$595.4K
YoY Change 59444.0%
Income Tax
% Of Pretax Income
Net Earnings -$595.4K
YoY Change 59444.0%
Net Earnings / Revenue
Basic Earnings Per Share -$1.57
Diluted Earnings Per Share -$50.54K
COMMON SHARES
Basic Shares Outstanding 9.638M shares
Diluted Shares Outstanding 9.638M shares

Balance Sheet

Concept 2021 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $518.9K
YoY Change 1975.64%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $73.87K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $592.8K
YoY Change 2271.08%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $174.2M
YoY Change
Total Long-Term Assets $174.2M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $592.8K
Total Long-Term Assets $174.2M
Total Assets $174.8M
YoY Change 699192.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $153.6K
YoY Change
Accrued Expenses $82.83K
YoY Change 8183.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $333.6K
YoY Change 33263.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $7.973M
YoY Change
Total Long-Term Liabilities $7.973M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $333.6K
Total Long-Term Liabilities $7.973M
Total Liabilities $8.307M
YoY Change 830588.0%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $166.5M
YoY Change
Total Liabilities & Shareholders Equity $174.8M
YoY Change 699192.8%

Cashflow Statement

Concept 2021 2020 Q2
OPERATING ACTIVITIES
Net Income -$595.4K
YoY Change 59444.0%
Depreciation, Depletion And Amortization $365.1K
YoY Change
Cash From Operating Activities -$1.040M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$174.2M
YoY Change
Cash From Investing Activities -$174.2M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $3.672M
YoY Change 14589.34%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 175.8M
YoY Change 702934.88%
NET CHANGE
Cash From Operating Activities -1.040M
Cash From Investing Activities -174.2M
Cash From Financing Activities 175.8M
Net Change In Cash 493.9K
YoY Change 1875.64%
FREE CASH FLOW
Cash From Operating Activities -$1.040M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
claqu Warrant Issuance Costs
WarrantIssuanceCosts
USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
USD
us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
USD
us-gaap Other Noncash Expense
OtherNoncashExpense
USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
USD
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
USD
us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
USD
us-gaap Franchisor Costs
FranchisorCosts
USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
USD
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001849820
CY2020Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2020Q4 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
USD

Files In Submission

Name View Source Status
0001213900-22-015818-index-headers.html Edgar Link pending
0001213900-22-015818-index.html Edgar Link pending
0001213900-22-015818.txt Edgar Link pending
0001213900-22-015818-xbrl.zip Edgar Link pending
claqu-20211231.xsd Edgar Link pending
claqu-20211231_cal.xml Edgar Link unprocessable
claqu-20211231_def.xml Edgar Link unprocessable
claqu-20211231_lab.xml Edgar Link unprocessable
claqu-20211231_pre.xml Edgar Link unprocessable
f10k2021ex31-1_cleantech.htm Edgar Link pending
f10k2021ex31-2_cleantech.htm Edgar Link pending
f10k2021ex32-1_cleantech.htm Edgar Link pending
f10k2021ex32-2_cleantech.htm Edgar Link pending
f10k2021ex4-6_cleantech.htm Edgar Link pending
f10k2021ex99-4_cleantech.htm Edgar Link pending
f10k2021_cleantechacq.htm Edgar Link pending
f10k2021_cleantechacq_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending